Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 521-530 of 2762 for

Edit search filters
  1. Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

    Rochester, MN

  2. Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy

    Rochester, MN

  3. Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients with Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies

    Rochester, MN

  5. Combination Chemotherapy in Treating Patients with Non-Metastatic Extracranial Ewing Sarcoma

    Rochester, MN

  6. Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients

    Rochester, MN

  7. A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma

    Rochester, MN

  9. A Study of JNJ‐68284528 Out‐of‐Specification (OOS) for Commercial Release in Patients with Multiple Myeloma

    Rochester, MN

  10. Daunorubicin Hydrochloride, Cytarabine, and Nilotinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer